Based on Simulations Plus’ latest earnings report for the quarter ending February 28, the company posted quarterly revenue of $8.47 million and quarterly net profit of $2.1 million. In comparison, last year the company earned revenue of $7.36 million and had a net profit of $3.47 million. SLP’s market cap is $382.7M and the company has a P/E ratio of 54.40. Currently, Simulations Plus has an average volume of 6,709.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.